EP
ABBV icon

Essential Partners’s AbbVie ABBV Stock Holding History

Essential Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40K Buy
159
+18
+13% +$3.87K 0.02% 669
2026
Q1 		$30.7K Sell
141
-42
-23% -$9.32K 0.01% 757
2025
Q4 		$41.9K Buy
183
+7
+4% +$1.59K 0.01% 658
2025
Q3 		$40.8K Buy
176
+127
+259% +$25.9K 0.01% 651
2025
Q2 		$9.1K Buy
+49
New +$9.11K ﹤0.01% 874

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Essential Partners's ABBV Position: Q2 2026 in Review

Essential Partners increased its AbbVie (ABBV) stake by 13% in Q2 2026, buying an estimated $3.87K and bringing the position to 159 shares worth $40K. The position accounts for 0.02% of the portfolio, ranked #669.

Essential Partners first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. The position peaked at $41.9K in Q4 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Essential Partners held 159 shares of AbbVie worth $40K as of Q2 2026.
  • Essential Partners bought 18 AbbVie shares in Q2 2026, an estimated $3.87K.
  • AbbVie made up 0.02% of Essential Partners's portfolio in Q2 2026, its #669 holding.
  • Essential Partners first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's AbbVie position peaked at $41.9K in Q4 2025.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.